Cotinga Pharmaceuticals Inc (COTQF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
Cotinga Pharmaceuticals EPS Diluted (Quarterly): -0.0152 for Jan. 31, 2020
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2020 | -0.0152 |
| October 31, 2019 | -0.0151 |
| July 31, 2019 | -0.0151 |
| April 30, 2019 | -0.03 |
| January 31, 2019 | -0.0075 |
| October 31, 2018 | -0.0153 |
| July 31, 2018 | -0.0307 |
| April 30, 2018 | -0.0785 |
| January 31, 2018 | -0.0632 |
| October 31, 2017 | -0.0879 |
| July 31, 2017 | -0.0151 |
| April 30, 2017 | -0.0977 |
| January 31, 2017 | -0.06 |
| October 31, 2016 | -0.0382 |
| July 31, 2016 | -0.1235 |
| April 30, 2016 | -0.1429 |
| January 31, 2016 | -0.0729 |
| October 31, 2015 | -0.076 |
| July 31, 2015 | -0.0802 |
| April 30, 2015 | -0.08 |
| January 31, 2015 | -0.0859 |
| October 31, 2014 | -0.0905 |
| July 31, 2014 | -0.0925 |
| April 30, 2014 | -0.0904 |
| January 31, 2014 | -0.0936 |
| Date | Value |
|---|---|
| October 31, 2013 | -0.0964 |
| July 31, 2013 | -0.097 |
| April 30, 2013 | 0.00 |
| January 31, 2013 | -0.1007 |
| October 31, 2012 | -0.1014 |
| July 31, 2012 | -0.0982 |
| April 30, 2012 | -0.1005 |
| January 31, 2012 | -0.0979 |
| October 31, 2011 | -0.0998 |
| July 31, 2011 | -0.1034 |
| April 30, 2011 | -0.1025 |
| January 31, 2011 | -0.0995 |
| October 31, 2010 | -0.097 |
| July 31, 2010 | -0.0959 |
| April 30, 2010 | -0.1946 |
| January 31, 2010 | -0.1899 |
| October 31, 2009 | -0.1862 |
| July 31, 2009 | -0.1766 |
| April 30, 2009 | -0.1609 |
| January 31, 2009 | -0.163 |
| October 31, 2008 | -0.1827 |
| July 31, 2008 | -0.198 |
| April 30, 2008 | -0.1989 |
| January 31, 2008 | -0.1006 |
| October 31, 2007 | -0.0983 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.0152
Minimum
Jan 2020
-0.0152
Maximum
Jan 2020
-0.0152
Average
-0.0152
Median
Jan 2020
EPS Diluted (Quarterly) Benchmarks
| Biosyntech Inc | -- |
| The Flowr Corp | -0.0077 |
| Canntab Therapeutics Ltd | -0.0074 |
| Medical International Technology Inc | -- |
| BZAM Ltd | -0.0671 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.4055M |
| Total Expenses (Quarterly) | 0.3578M |